drugset / Trial / NCT06620393

Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients

NCT06620393

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Agitation is a frequent complication following traumatic braing injury in patients admitted to the intensive care unit. This agitation frequently results in the liberal use of rescue drugs such as antipsychotics, sedatives and opiates, which in turn may delay rehabilitation, liberation from mechanical ventilation and emergence from posttraumatic amnesia. Dexmedetomidine may be a better agent given it's light sedative properties. The main objective is to assess the feasibility of conducting a multicenter randomized controlled trial of dexmedetomidine following TBI in the ICU.

Timeline

Start
2024-10-01
Primary completion
2026-06-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1.4 ug/kg